These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10086586)

  • 1. Abciximab and the risk of bleeding during emergency cardiac operations.
    Arjomand H; Mascarenhas DA; Morgan RJ
    Ann Thorac Surg; 1999 Jan; 67(1):292-3. PubMed ID: 10086586
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic platelet transfusion in abciximab-treated patients requiring emergency coronary bypass surgery.
    Kereiakes DJ
    Am J Cardiol; 1998 Feb; 81(3):373. PubMed ID: 9468091
    [No Abstract]   [Full Text] [Related]  

  • 3. Routine platelet transfusion in patients undergoing emergency coronary bypass surgery after receiving abciximab.
    Juergens CP; Yeung AC; Oesterle SN
    Am J Cardiol; 1997 Jul; 80(1):74-5. PubMed ID: 9205024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience in coronary bypass surgery for abciximab-treated patients.
    Lemmer JH
    Ann Thorac Surg; 2000 Aug; 70(2 Suppl):S33-7. PubMed ID: 10966008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications.
    Boehrer JD; Kereiakes DJ; Navetta FI; Califf RM; Topol EJ
    Am J Cardiol; 1994 Dec; 74(11):1166-70. PubMed ID: 7977081
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimally invasive bypass surgery.
    Dragu RE
    N Engl J Med; 2002 Dec; 347(26):2165-8; author reply 2165-8. PubMed ID: 12501850
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of coronary artery perforation in patients receiving abciximab.
    Del Campo C; Zelman R
    Catheter Cardiovasc Interv; 2001 Sep; 54(1):139-40. PubMed ID: 11553964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adjuvant therapy with a glycoprotein IIb-IIa inhibitor (abciximab) in coronary angioplasties with a high thrombotic risk].
    Matos V; Marques AM; Oliveira H; Ramos D; Lopes P; Camacho M; Gonsalves A
    Rev Port Cardiol; 1998 Dec; 17(12):1001-5. PubMed ID: 9973861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic abciximab in elective coronary stenting: results of a randomized trial.
    Tamburino C; Russo G; Nicosia A; Galassi AR; Foti R; Scriffignano V; Kereiakes DJ; Giuffrida G
    J Invasive Cardiol; 2002 Feb; 14(2):72-9. PubMed ID: 11818641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quick resolution with abciximab of giant coronary thrombus].
    Delcán Domínguez JL; García Fernández E; Guerrero Sanz JE
    Rev Esp Cardiol; 2002 May; 55(5):536. PubMed ID: 12015935
    [No Abstract]   [Full Text] [Related]  

  • 11. Abciximab extends treatment window for stroke.
    Burton A
    Lancet Neurol; 2003 Jul; 2(7):390. PubMed ID: 12849109
    [No Abstract]   [Full Text] [Related]  

  • 12. Avoidance of adverse events in restenotic lesions with abciximab?
    Linnemeier TJ
    J Invasive Cardiol; 2000 Nov; 12(11):545-6. PubMed ID: 11060564
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.
    Greenbaum AB; Grines CL; Bittl JA; Becker RC; Kereiakes DJ; Gilchrist IC; Clegg J; Stankowski JE; Grogan DR; Harrington RA; Emanuelsson H; Weaver WD
    Am Heart J; 2006 Mar; 151(3):689.e1-689.e10. PubMed ID: 16504633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of abciximab in the prevention of the acute thrombotic complications of coronary angioplasty].
    Mesquita A; Baptista J; Almeida M; Ferreira J; Machado F; Palos L; Silva A; Seabra-Gomes R
    Rev Port Cardiol; 1997 Dec; 16(12):1031-5. PubMed ID: 9522626
    [No Abstract]   [Full Text] [Related]  

  • 15. On the use of abciximab in percutaneous coronary intervention.
    Iversen AZ
    Dan Med Bull; 2011 Aug; 58(8):B4312. PubMed ID: 21827726
    [No Abstract]   [Full Text] [Related]  

  • 16. [Abciximab].
    Yokoyama K; Ikeda Y
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():627-9. PubMed ID: 17465067
    [No Abstract]   [Full Text] [Related]  

  • 17. Abciximab: IIb or not IIb, is that still the question?
    Patel S; Perera D; Redwood S
    Int J Clin Pract; 2003; 57(1):5-7. PubMed ID: 12587933
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute platelet inhibition with abciximab does not reduce in-stent restenosis.
    Malik I; Poullis M
    Circulation; 2000 Oct; 102(15):E110. PubMed ID: 11023950
    [No Abstract]   [Full Text] [Related]  

  • 19. Bridge to operation with the GPIIb/IIIa inhibitor abciximab in high-risk coronary patients.
    Schoenhoff F; Kayhan N; Thomas G; Haase KK; Borggrefe M; Katus HA; Hagl S; Vahl CF
    Thorac Cardiovasc Surg; 2006 Apr; 54(3):150-6. PubMed ID: 16639674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Large arterial thrombosis. Rapid recanalization with a new thrombocyte inhibitor].
    Berglund U; Stenport G
    Lakartidningen; 1997 Oct; 94(40):3524-6. PubMed ID: 9411093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.